AI assistant
Sending…
IGC Pharma, Inc. — Director's Dealing 2009
May 18, 2009
34705_dirs_2009-05-18_6a6e17c0-08dc-46a8-9bec-926da19ab9e7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2009-05-15
Reporting Person: PRINS RICHARD K (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-05-13 | ESOP (right to buy) | $1 | A | 125000 | Acquired | 2014-05-13 | Common Stock (125000) | Direct |
Footnotes
F1: The derivative securities include an option to purchase 71,250 units at $7.50 each. The Unit consists of one share of common stock and two warrants exercisable at $6.50 per warrant. The option expires on March 2, 2012.
More from IGC Pharma, Inc.
Capital/Financing Update
2026
Jun 8
Interim / Quarterly Report
2026
May 15
Capital/Financing Update
2026
Apr 20
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 18
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Jan 20
Capital/Financing Update
2026
Jan 6
Regulatory Filings
2026
Jan 2
Capital/Financing Update
2025
Dec 15